Recently, the Canadian Department of Finance released a draft regulation on the consumption tax of e-cigarette products. According to the draft regulation, e-cigarette products will be subject to new tax provisions. The following are the main contents of the draft regulation:
The bill will apply to e-cigarette products produced or imported within Canada. E-cigarette products manufactured or imported within Canada will be subject to a specific provincial sales tax based on their intended use and point of sale. The designated e-cigarette provinces include Ontario, Quebec, the Northwest Territories, and Nunavut. Untaxed e-cigarette products will also be subject to the provincial sales tax when sold in the designated e-cigarette provinces. The legislation also includes provisions for a transition period, which will be implemented from July 1 to September 30, 2024. Additionally, in order to facilitate the coordinated implementation of the e-cigarette taxation system, the relevant regulations will not apply to certain e-cigarette products until October 1, 2024.
The release of this draft regulation has sparked the attention of various sectors of society, particularly the industry and consumer groups related to e-cigarettes. With the increasing popularity of e-cigarettes in the Canadian market, the implementation of this regulation will have a significant impact on the e-cigarette market and consumers.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
